Multimodality Treatment De-Intensification in Low-Risk Breast Cancer: What Are the Limits?
In this journal activity, participants will review the rationale for de-intensifying treatments for node-negative, hormone-receptor positive breast cancer. This activity will enable participants to be able to discuss de-escalation studies in surgery, systemic therapy and radiotherapy.
Category
  • Breast
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $49.00

Pages